The U.S. Food and Drug Administration (FDA) issued a heavy warning about gout medication, Uloric, in January 2019. The black box warning that was issued is the strictest labeling requirement that the FDA can mandate on prescription medication and highlights the high risk of adverse drug reactions. It warns patients that the side effects may outweigh any benefits associated with taking the medication. Uloric has been linked to an increased chance of cardiovascular issues and even death. Patients who have suffered adverse effects after taking this drug will be searching for a drug injury law firm who can help them file a lawsuit against the manufacturers of Uloric.
In February 2019, the FDA warned that there was an increased risk of death for patients who were taking Uloric to treat gout. Based on the risk of heart attacks caused by the drug, the FDA ordered that the product include a black box warning on the box – the highest form of warning for a medical device or pharmaceutical – that discloses the increased risk of death. Currently, plaintiffs’ attorneys are in the investigatory phase of filing lawsuits against Takeda Pharmaceuticals. This means that they are interviewing possible plaintiffs and preparing claims that will be filed in court. In May 2019, the first claims were filed in court against Takeda. Given that the side effect of the medication is death, it is likely that damages will be high if juries find that the manufacturer introduced a defective product into the marketplace. It is anticipated that additional lawsuits will be filed against Takeda in the near future. Since the lawsuits have just been filed, the discovery and selection of bellwether cases are still far off and the scope of this lawsuit is still unfolding.
Broughton Partners Will Find Qualified Uloric Lawsuit Leads
Our case generation services connect Uloric injury attorneys with patients who need legal assistance. Potential plaintiffs will search online for legal information related to Uloric lawsuits. Victims are looking to hire professional drug injury lawyers to get compensation for their injuries, medical bills, and lost wages.
Broughton Partners wants to help your law firm by creating an effective campaign for high-quality Uloric lawsuit leads and providing you with potential Uloric cases to increase your revenue. Victims of dangerous drugs such as Ulroic are able to find legal help via our network of websites and targeted online advertising.
Receive Fully Vetted & Signed Uloric Lawsuit Leads
Broughton Partners’ goal is to provide law firms with case-ready Uloric plaintiffs. The cases that we deliver to law firms are prepared with the necessary case information, documents, and history that you need to immediately start working on the case. The Uloric lawsuit leads that are provided by our services are real victims who have legitimate Uloric cases. Our innovative case-acquisition platform is always being monitored and optimized to track only quality Uloric leads. We have an industry-leading team and case-acquisition process that allows Broughton Partners to deliver the Uloric Lawsuit cases your law firm wants.
It can be difficult to find Uloric lawsuit leads, especially leads that are high-quality and case-ready. Save time and let us do the work for you by examining potential Uloric lawsuit leads and delivering only the best cases to your law firm.
How Does Broughton Partners Acquire Uloric Lawsuit Leads?
Our experienced in-house marketing team begins by targeting and connecting with victims that are searching for information about Uloric and if they have a lawsuit. We then begin tracking Uloric lawsuit leads online with our industry-leading case-acquisition platform as soon as potential Uloric plaintiffs show interest or after they call. Our system is constantly being updated and optimized so that only qualified leads are being delivered to law firms.
Our in-house call center is open and working 24 hours with multi-lingual specialists. Each of our intake associates are highly trained individuals who know how to handle intake sessions with quality and compassion. The Uloric cases we come into contact with will be reviewed will by our in-house call center via customized questions and a qualification process that is based on your law firm’s Uloric case criteria.
When our team finds a qualified Uloric lawsuit lead, we then gather appropriate case documents that your law firm would need to start working the case right away.
What is Uloric?
Uloric, also called Febuxostat, is a medication that doctors prescribe to treat gout, a condition where needle-like crystals of uric acid form in a person’s joints, causing inflammation and pain. The drug is prescribed by physicians to reduce the amount of acid, thereby reducing inflammation and other symptoms of gout.
Takeda Pharmaceuticals created this gout medication and introduced it to the public in February 2009. Uloric is the first medication for gout to be introduced on the market in over 40 years. During the five-year period from 2012 to 2017, the company is reported to have made around $1.9 billion from the sale of Uloric. The medication became one of the top prescribed brand-name drugs in 2015.
A stipulation for Uloric’s approval by the FDA required the manufacturer to conduct post-market safety clinical trials on 6,000 individuals using the drug. During these clinical trials, it was revealed that 15 out of every 1,000 gout patients taking Uloric suffered damaging health effects as a result of taking the drug, meaning 90 out of the 6,000 people participating in the clinical trials were injured by the dangerous medication. Additionally, 26 out of every 1,000 Uloric users died in a year. As a comparison, these study results were measured against the clinical trials of another medication called Allopurinol and showed only 22 Allopurinol users per 1,000 died in a year, but these 22 users had both gout and cardiovascular disease.
The study connected Uloric to causing cardiovascular problems and showed that more patients taking it experienced cardiovascular death than patients on the drug Allopurinol. Because of these study results, a Black Box warning was added to Uloric by the FDA.
Uloric Side Effects
It is important to note that a Black Box warning on medication is not issued lightly by the FDA. If serious side effects continue to occur, the FDA may issue a total recall of Uloric. If this happens, Uloric will no longer be prescribed and will be completely removed from the market.
Gout patients who are taking the drug and are experiencing any of the following symptoms will need a dangerous drug attorney to help them fight for compensation.
- Chest pain
- Shortness of breath
- Rapid or irregular heartbeat
- Trouble speaking
- Sudden severe headache
- Numbness or weakness on one side of the body
Potential Harm from Taking Uloric
Patients taking Uloric must be aware that there are very high risks associated with taking this medication. One of the very serious side effects is cardiac death. In the study with 6,000 participants that Takeda Pharmaceuticals conducted, it was discovered that some of the participants experienced inadequate blood supply to the heart, non-fatal heart attack or non-fatal stroke. Emergency surgery was often needed in these situations.
Another side effect of taking Uloric is kidney failure. Before September 2017, Takeda did not include information about dosing recommendations for those patients who had gout plus severe kidney impairment. Only after a number of patients complained about renal injury did the manufacturer begin to include such recommendations with the medication. With the current labeling, the dosage is limited to a maximum of 40 mg per day.
Case Criteria for Uloric Lawsuit Leads
Patients who have suffered Uloric injuries will want to file a drug injury lawsuit against the responsible parties. These Uloric lawsuit leads need help to claim compensation for their injuries, the cost of medical treatment, lost wages, and pain and suffering. There are specific elements that every plaintiff must prove in order to win a Uloric lawsuit.
Broughton Partners will only deliver quality Uloric Lawsuit leads that are pre-qualified and match the case criteria specified by your law firm. Our team of trained specialists will be examining the eligibility of cases and whether or not a patient’s claim qualifies for a Uloric lawsuit. Our case intake system is built upon unique parameters and algorithms that allow us to dynamically improve case quality and conversion. We do this by running potential plaintiffs through specialized questions and a qualification process based on your law firm’s desired criteria. The Uloric lawsuit leads that your law firm will receive will be questioned and examined to ensure that they are quality retained plaintiffs.
The Uloric lawsuit leads that Broughton Partners will deliver must meet the following criteria:
- Uloric’s defect caused injury or death.
- Uloric was defective and caused kidney or heart problems.
- Uloric was taken exactly as prescribed.
- Uloric was used as intended/directed by Takeda Pharmaceuticals.
In some drug injury cases, it is not necessary for the plaintiff to prove that the manufacturer was negligent. To win in other types of personal injury cases, however, the plaintiff is required to show that the defendant was negligent. Based on strict liability, the manufacturer is held responsible when harm is caused due to a dangerous drug. Whether Takeda Pharmaceuticals did or did not know that Uloric would harm patients does not matter. The company is responsible for harm that its product caused to the people who used the medication.
Is Your Law Firm Looking For Uloric Lawsuit Leads
Victims who have suffered injuries due to the use of Uloric are actively seeking experienced drug injury attorneys for legal representation. Broughton Partners’ case generation service connects your law firm with Uloric lawsuit leads who are already qualified and signed.
If your law firm is looking to help more Uloric lawsuit leads, then call Broughton Partners today at (855) 463-1735, or contact us for a free consultation. Our trained specialists will discuss how our Uloric lawsuit case-acquisition process works and how Broughton Partners can get prequalified Uloric lawsuit leads you want.
- FDA. “FDA adds Boxed Warning for increased risk of death with gout medicine Uloric (febuxostat)“, U.S. Department of Health and Human Services, https://www.fda.gov/Drugs/DrugSafety/ucm631182.htm. Accessed March 8, 2019.
- Mark Terry. “Consumer Group Pressures FDA to Pull Takeda’s Gout Drug Off the Market“, BioSpace, https://www.biospace.com/article/consumer-group-pressures-fda-to-pull-takeda-s-gout-drug-off-the-market/. Accessed March 18, 2019.
- WebMD. “Uloric Side Effects by Likelihood and Severity“, WebMD, https://www.webmd.com/drugs/2/drug-151872/uloric-oral/details/list-sideeffects. Accessed March 18, 2019.